{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:02:26Z","timestamp":1792414946353,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ebiom.2023.104814","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:32:49Z","timestamp":1697157169000},"page":"104814","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Efficacy and safety of ivermectin for the treatment of Plasmodium falciparum infections in asymptomatic male and female Gabonese adults \u2013 a pilot randomized, double-blind, placebo-controlled single-centre phase Ib\/IIa clinical trial"],"prefix":"10.1016","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8980-3149","authenticated-orcid":false,"given":"Dorothea","family":"Ekoka Mbassi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghyslain","family":"Mombo-Ngoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Held","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dearie Glory","family":"Okwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8213-4912","authenticated-orcid":false,"given":"Wilfrid","family":"Ndzebe-Ndoumba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Charlotte","family":"Kalkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck Aurelien","family":"Ekoka Mbassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lais","family":"Pessanha de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malik Azeez","family":"Akinosho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia Betty","family":"Dimessa Mbadinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel Koffi","family":"Yovo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9101-2768","authenticated-orcid":false,"given":"Benjamin","family":"Mordm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Gottfried","family":"Kremsner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u00f4la Akim","family":"Adegnika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ramharter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7425-2794","authenticated-orcid":false,"given":"Rella","family":"Zoleko-Manego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6872","key":"10.1016\/j.ebiom.2023.104814_bib1","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/415680a","article-title":"The economic and social burden of malaria","volume":"415","author":"Sachs","year":"2002","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104814_bib2","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrmicro.2017.161","article-title":"Drug resistance in plasmodium","volume":"16","author":"Haldar","year":"2018","journal-title":"Nat Rev Microbiol"},{"issue":"41","key":"10.1016\/j.ebiom.2023.104814_bib3","first-page":"457","article-title":"Global programme to eliminate lymphatic filariasis: progress report 2018","volume":"94","author":"Organization","year":"2019","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.ebiom.2023.104814_bib4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1242\/jeb.142.1.191","article-title":"The insecticide avermectin b (la) activates a chloride channel in crayfish muscle membrane","volume":"142","author":"Zufall","year":"1989","journal-title":"J\u00a0Exp Biol"},{"issue":"10180","key":"10.1016\/j.ebiom.2023.104814_bib5","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0140-6736(18)32613-8","article-title":"Advancing the repurposing of ivermectin for malaria","volume":"393","author":"Chaccour","year":"2019","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104814_bib6","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.2196\/resprot.6617","article-title":"Efficacy and safety of high-dose ivermectin for reducing malaria transmission (IVERMAL): protocol for a double-blind, randomized, placebo-controlled, dose-finding trial in western Kenya","volume":"5","author":"Smit","year":"2016","journal-title":"JMIR Res Protoc"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104814_bib7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/1475-2875-9-365","article-title":"Mass drug administration of ivermectin in south-eastern Senegal reduces the survivorship of wild-caught, blood fed malaria vectors","volume":"9","author":"Sylla","year":"2010","journal-title":"Malar J"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104814_bib8","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/cid\/ciy1063","article-title":"Human direct skin feeding versus membrane feeding to assess the mosquitocidal efficacy of high-dose ivermectin (IVERMAL trial)","volume":"69","author":"Smit","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104814_bib9","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1473-3099(18)30163-4","article-title":"Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trial","volume":"18","author":"Smit","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ebiom.2023.104814_bib10","series-title":"Ivermectin for malaria transmission control","author":"Meeting Mpac","year":"2016"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104814_bib11","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1473-3099(19)30633-4","article-title":"Ivermectin as a novel complementary malaria control tool to reduce incidence and prevalence: a modelling study","volume":"20","author":"Slater","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104814_bib12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1128\/AAC.00085-19","article-title":"Ivermectin impairs the development of sexual and asexual stages of plasmodium falciparum in\u00a0vitro","volume":"63","author":"de Carvalho","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104814_bib13","doi-asserted-by":"crossref","first-page":"e994","DOI":"10.1038\/cddis.2013.521","article-title":"Plasmodium falciparum signal recognition particle components and anti-parasitic effect of ivermectin in blocking nucleo-cytoplasmic shuttling of SRP","volume":"5","author":"Panchal","year":"2014","journal-title":"Cell Death Dis"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104814_bib14","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/tmi.13357","article-title":"Ivermectin for causal malaria prophylaxis: a randomised controlled human infection trial","volume":"25","author":"Metzger","year":"2020","journal-title":"Trop Med Int Health"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104814_bib15","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1586\/eri.13.45","article-title":"The silent threat: asymptomatic parasitemia and malaria transmission","volume":"11","author":"Lindblade","year":"2013","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104814_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001942","article-title":"\"Asymptomatic\" malaria: a chronic and debilitating infection that should Be treated","volume":"13","author":"Chen","year":"2016","journal-title":"PLoS Med"},{"issue":"14","key":"10.1016\/j.ebiom.2023.104814_bib17","doi-asserted-by":"crossref","first-page":"9711","DOI":"10.1021\/acs.jmedchem.1c00498","article-title":"Ivermectin: a promising therapeutic for fighting malaria. Current status and perspective","volume":"64","author":"Singh","year":"2021","journal-title":"J\u00a0Med Chem"},{"issue":"9\u201310","key":"10.1016\/j.ebiom.2023.104814_bib18","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s00508-020-01794-8","article-title":"Development of sustainable research excellence with a global perspective on infectious diseases: centre de Recherches Medicales de Lambarene (CERMEL), Gabon","volume":"133","author":"Ramharter","year":"2021","journal-title":"Wien Klin Wochenschr"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104814_bib19","doi-asserted-by":"crossref","first-page":"939","DOI":"10.4269\/ajtmh.2007.77.939","article-title":"High prevalence of asymptomatic Plasmodium falciparum infection in Gabonese adults","volume":"77","author":"Dal-Bianco","year":"2007","journal-title":"Am J Trop Med Hyg"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104814_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009623","article-title":"Diagnostic performance of capillary and venous blood samples in the detection of Loa loa and Mansonella perstans microfilaraemia using light microscopy","volume":"15","author":"Mischlinger","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"10.1016\/j.ebiom.2023.104814_bib21","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S1473-3099(20)30256-5","article-title":"Burden of disease in Gabon caused by loiasis: a cross-sectional survey","volume":"20","author":"Veletzky","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.ebiom.2023.104814_bib22","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/1475-2883-2-S1-S4","article-title":"Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon","volume":"2 Suppl 1","author":"Boussinesq","year":"2003","journal-title":"Filaria J"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104814_bib23","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/cpt.1219","article-title":"Pharmacokinetics-pharmacodynamics of high-dose ivermectin with dihydroartemisinin-piperaquine on mosquitocidal activity and QT-prolongation (IVERMAL)","volume":"105","author":"Smit","year":"2019","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104814_bib24","doi-asserted-by":"crossref","first-page":"599","DOI":"10.4269\/ajtmh.2001.65.599","article-title":"Comparison of methods for the rapid laboratory assessment of children with malaria","volume":"65","author":"Planche","year":"2001","journal-title":"Am J Trop Med Hyg"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104814_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071539","article-title":"Multiplex qPCR for detection and absolute quantification of malaria","volume":"8","author":"Kamau","year":"2013","journal-title":"PLoS One"},{"issue":"7642","key":"10.1016\/j.ebiom.2023.104814_bib26","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature21060","article-title":"Sterile protection against human malaria by chemoattenuated PfSPZ vaccine","volume":"542","author":"Mordmuller","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2023.104814_bib27","author":"Chatfield"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104814_bib28","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/1475-2875-13-234","article-title":"Limit of blank and limit of detection of plasmodium falciparum thick blood smear microscopy in a routine setting in Central Africa","volume":"13","author":"Joanny","year":"2014","journal-title":"Malar J"},{"key":"10.1016\/j.ebiom.2023.104814_bib29","author":"Inc. TFS"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104814_bib30","first-page":"249","article-title":"Model-based imputation approach for data analysis in the presence of non-detects","volume":"53","author":"Krishnamoorthy","year":"2009","journal-title":"Ann Occup Hyg"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104814_bib32","first-page":"CD013117","article-title":"Ivermectin treatment in humans for reducing malaria transmission","volume":"6","author":"de Souza","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"10180","key":"10.1016\/j.ebiom.2023.104814_bib33","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0140-6736(18)32321-3","article-title":"Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): a cluster-randomised trial","volume":"393","author":"Foy","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104814_bib34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4269\/ajtmh.2011.11-0160","article-title":"Ivermectin mass drug administration to humans disrupts malaria parasite transmission in Senegalese villages","volume":"85","author":"Kobylinski","year":"2011","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104814_bib35","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/1475-2875-13-417","article-title":"Evaluation of ivermectin mass drug administration for malaria transmission control across different West African environments","volume":"13","author":"Alout","year":"2014","journal-title":"Malar J"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104814_bib36","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(21)00557-0","article-title":"Mass drug administration of ivermectin and dihydroartemisinin-piperaquine against malaria in settings with high coverage of standard control interventions: a cluster-randomised controlled trial in the Gambia","volume":"22","author":"Dabira","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ebiom.2023.104814_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.594653","article-title":"Naturally acquired humoral immunity against plasmodium falciparum malaria","volume":"11","author":"Gonzales","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2023.104814_bib38","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.63838","article-title":"Inducible mechanisms of disease tolerance provide an alternative strategy of acquired immunity to malaria","volume":"10","author":"Nahrendorf","year":"2021","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104814_bib39","first-page":"35","article-title":"[A study in the Ivory Coast (1985-1987) of the efficacy and tolerance of ivermectin (Mectizan) in human onchocerciasis. I. A comparative double-blind study of\u00a0220 patients with onchocerciasis treated with a single oral dose of\u00a0100, 150 or 200 mcg\/kg]","volume":"82","author":"Lariviere","year":"1989","journal-title":"Bull Soc Pathol Exot Filiales"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104814_bib40","first-page":"131","article-title":"The chemotherapy of onchocerciasis. XIX: the clinical and laboratory tolerance of high dose ivermectin","volume":"46","author":"Awadzi","year":"1995","journal-title":"Trop Med Parasitol"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104814_bib41","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0035-9203(99)90305-X","article-title":"The effects of high-dose ivermectin regimens on onchocerca volvulus in onchocerciasis patients","volume":"93","author":"Awadzi","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104814_bib42","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.trstmh.2003.10.018","article-title":"Adverse systemic reactions to treatment of onchocerciasis with ivermectin at normal and high doses given annually or three-monthly","volume":"98","author":"Kamgno","year":"2004","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104814_bib43","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1177\/009127002237994","article-title":"Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects","volume":"42","author":"Guzzo","year":"2002","journal-title":"J\u00a0Clin Pharmacol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423003808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423003808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:28:49Z","timestamp":1762457329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396423003808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":42,"alternative-id":["S2352396423003808"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104814","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of ivermectin for the treatment of Plasmodium falciparum infections in asymptomatic male and female Gabonese adults \u2013 a pilot randomized, double-blind, placebo-controlled single-centre phase Ib\/IIa clinical trial","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104814","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104814"}}